fda glp-1 warning september 2025 news Alarming rise in weight loss drug overdoses FDA Issues 30 Warning Letters

Sample Timing We generally recommend a 9am sample for thyroid testing

What they found: Plasma NAD+ did not rise directly , it was rapidly metabolized Plasma nicotinamide and methyl-nicotinamide rose markedly , markers of NAD+ metabolism NAD+ likely reaches tissues as its metabolites (not as whole NAD+) Clinically, patients subjectively reported increased energy during and after the infusion No serious adverse events during the 6-hour IV infusion Why it matters: The study provides rare clinical data on IV NAD+ , the administration route used by NAD+ clinics off-label

Screen time in the final hour or two before bed interferes with natural melatonin production due to blue light exposure

[2] Folic acid is relatively nontoxic in man